Randal J. Meyer, who recently joined McGuireWoods Consulting as a senior vice president for federal government affairs and McGuireWoods law firm as counsel in Washington, co-authored a Nov. 22 op-ed column published in The Wall Street Journal.
Bolsters inbound business expansion capabilities, offers unique insights
Randal J. Meyer has joined McGuireWoods Consulting as senior vice president in the firm’s federal public affairs team in Washington, D.C.
On Thursday, Nov. 8, McGuireWoods Consulting senior advisor, Frank Donatelli, participated in an event hosted by the Smithsonian Associates in Washington, D.C., “What the Midterm Elections Reveal About America.”
In a Nov. 9 Law360 article, McGuireWoods Consulting senior advisor, Frank Donatelli, reviewed the 2018 midterm elections with ten snap observations.
Lawmakers in Georgia will convene at the State Capitol on Jan. 14, 2019, for the first session of the 155th General Assembly. In addition to adopting a budget for the 2020 fiscal year, which is the only constitutionally required duty of the Georgia General Assembly, much of the activity during the 40-day legislative session likely will take place behind the scenes.
Following the 2018 election, Illinois will be the bluest it has ever been in modern history. With incumbent Republican Gov. Bruce Rauner resoundingly losing his re-election bid to Democrat J.B. Pritzker, all statewide elected offices are held by Democrats.
While Congress may not be able to make up its mind on whether and how to permanently deal with cannabis legalization, the American people clearly have done so. In virtually every state with any kind of significant urban presence and direct voter access to the ballot, marijuana is in some stage of decriminalization.
Your weekly North Carolina political news report.
This Week: Congress focuses on organizing for the next Congress and the continuing resolution; previews of drug pricing legislation for the next Congress; CMS issues controversial guidance concerning how states can use subsidies.
An overview of the upcoming week in Congress from the McGuireWoods Consulting Tax Policy Update Team.
This month, President Trump announced his plan to lower drug prices. The plan does not call for a major overhaul of drug companies’ pricing practices, but does include some proposals that they oppose. Much of Trump’s plan is in the form of suggested actions, and it will take time for actual detailed proposals to be put forward.
The European Commission recently proposed a 3% tax on turnover for companies with EU digital revenues over €50 million and total global revenues over €750 million.